Loading
A phase 2 trial in pancreatic cancer, run by Mayo Clinic, now recruiting.
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer is a phase 2, randomised interventional study registered as NCT05969860 by Mayo Clinic, with a registry enrolment figure of 220 participants, started 2023-08-23 and due to reach its primary completion in 2027-01-01. Interventions recorded: Clinical Encounter; Home Health Encounter; Quality-of-Life Assessment; Questionnaire Administration. Conditions listed: Advanced Anal Carcinoma; Advanced Biliary Tract Carcinoma; Advanced Bladder Carcinoma; Advanced Breast Carcinoma; Advanced Carcinoid Tumor; Advanced Cervical Carcinoma; Advanced Colorectal Carcinoma; Advanced Gastric Carcinoma; Advanced Glioblastoma; Advanced Head and Neck Carcinoma; Advanced HER2 Positive Breast Carcinoma; Advanced Lung Carcinoma; Advanced Lung Small Cell Carcinoma; Advanced Malignant Germ Cell Tumor; Advanced Malignant Solid Neoplasm; Advanced Neuroendocrine Carcinoma; Advanced Ovarian Carcinoma; Advanced Pancreatic Carcinoma; Advanced Prostate Small Cell Neuroendocrine Carcinoma; Advanced Prostate Carcinoma; Hematopoietic and Lymphoid System Neoplasm; Multiple Myeloma; Myelodysplastic Syndrome; Advanced Basal Cell Carcinoma; Advanced Cholangiocarcinoma; Advanced Endometrial Carcinoma; Advanced Esophageal Carcinoma; Advanced Fallopian Tube Carcinoma; Advanced Hepatocellular Carcinoma; Advanced Liver Carcinoma; Advanced Lymphoma; Advanced Malignant Testicular Neoplasm; Advanced Melanoma; Advanced Merkel Cell Carcinoma; Advanced Penile Carcinoma; Advanced Primary Malignant Central Nervous System Neoplasm; Advanced Renal Cell Carcinoma; Advanced Sarcoma; Advanced Skin Squamous Cell Carcinoma; Advanced Urethral Carcinoma; Advanced Vaginal Carcinoma; Advanced Vulvar Carcinoma; Advanced Appendix Carcinoma; Advanced Gastroesophageal Junction Adenocarcinoma. Primary outcome: Mean patient-reported rating of Cancer Connected Access and Remote Expertise. Pancreatic eligibility wording from the registry: "* Pancreatic adenocarcinoma". Sites: United States. No results are recorded here; the registry entry is the source.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Pancreatic cancer trials open today (registry snapshot and UK sites), Metastatic pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.